Close Menu

NEW YORK (GenomeWeb News) – Life Technologies has entered into an agreement to establish a $750 million revolving credit facility, it disclosed in a document filed with the US Securities and Exchange Commission after the close of the market on Tuesday.

Bank of America is the administrative agent, swing line lender, and L/C issuer under the arrangement. Life Tech along with Applied Biosystems BV, Life Technologies Europe BV, and Life Technologies Finance Limited have the right to borrow under the facility.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Public health experts call for a transparent COVID-19 vaccine approval process in a letter; the Food and Drug Administration commissioner assures science-based approval.

The Verge reports that new gene-naming guidelines aim in part to avoid Excel-related name change confusion.

In Nature this week: tuatara genome sequence aids in understanding amniote evolution, and more.

According to the Guardian, UK virologists say in a letter to officials that their expertise has been pushed aside in COVID-19 response plans.